Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Jan 1;97(1):65–72. doi: 10.1172/JCI118408

Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein epsilon 4 allele.

N Bergeron 1, R J Havel 1
PMCID: PMC507063  PMID: 8550852

Abstract

The postprandial responses of apo B48, B100, E and lipids in triglyceride-rich lipoproteins (TRL) to a meal containing one-third of daily energy (39% fat calories) were compared in normolipidemic young men with apo E3/3 and apo E4/3 phenotypes. After the two groups consumed a diet rich in polyunsaturated fat for 15-29 d, their postabsorptive concentrations of TRL triglycerides, apo B48, and apo B100 were virtually identical, but their postprandial responses differed. In both groups, TRL apo B48 increased at 3 h but returned to postabsorptive values at 6 h only in the apo E3/3 group; in the apo E4/3 group the concentration of apo B48 at 6 h was 80% higher than postabsorptive values. TRL apo B100 also increased at 3 h in the two groups and fell to post-absorptive values at 6 h in the apo E3/3 group but remained 51% higher than postabsorptive concentrations in the apo E4/3 group; this response was closely coupled to that of TRL cholesterol and apo E. These observations suggest that clearance of intestinal and hepatogenous TRL remnants is impaired in young men with an apo E4/3 phenotype.

Full Text

The Full Text of this article is available as a PDF (179.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allain C. C., Poon L. S., Chan C. S., Richmond W., Fu P. C. Enzymatic determination of total serum cholesterol. Clin Chem. 1974 Apr;20(4):470–475. [PubMed] [Google Scholar]
  2. Boerwinkle E., Brown S., Sharrett A. R., Heiss G., Patsch W. Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations. Am J Hum Genet. 1994 Feb;54(2):341–360. [PMC free article] [PubMed] [Google Scholar]
  3. Bradley W. A., Gianturco S. H. ApoE is necessary and sufficient for the binding of large triglyceride-rich lipoproteins to the LDL receptor; apoB is unnecessary. J Lipid Res. 1986 Jan;27(1):40–48. [PubMed] [Google Scholar]
  4. Bradley W. A., Hwang S. L., Karlin J. B., Lin A. H., Prasad S. C., Gotto A. M., Jr, Gianturco S. H. Low-density lipoprotein receptor binding determinants switch from apolipoprotein E to apolipoprotein B during conversion of hypertriglyceridemic very-low-density lipoprotein to low-density lipoproteins. J Biol Chem. 1984 Dec 10;259(23):14728–14735. [PubMed] [Google Scholar]
  5. Brown A. J., Roberts D. C. The effect of fasting triacylglyceride concentration and apolipoprotein E polymorphism on postprandial lipemia. Arterioscler Thromb. 1991 Nov-Dec;11(6):1737–1744. doi: 10.1161/01.atv.11.6.1737. [DOI] [PubMed] [Google Scholar]
  6. Bucolo G., David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973 May;19(5):476–482. [PubMed] [Google Scholar]
  7. Campos E., Nakajima K., Tanaka A., Havel R. J. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100. J Lipid Res. 1992 Mar;33(3):369–380. [PubMed] [Google Scholar]
  8. Cardin A. D., Witt K. R., Chao J., Margolius H. S., Donaldson V. H., Jackson R. L. Degradation of apolipoprotein B-100 of human plasma low density lipoproteins by tissue and plasma kallikreins. J Biol Chem. 1984 Jul 10;259(13):8522–8528. [PubMed] [Google Scholar]
  9. Chait A., Onitiri A., Nicoll A., Rabaya E., Davies J., Lewis B. Reduction of serum triglyceride levels by polyunsaturated fat. Studies on the mode of action and on very low density lipoprotein composition. Atherosclerosis. 1974 Sep-Oct;20(2):347–364. doi: 10.1016/0021-9150(74)90017-3. [DOI] [PubMed] [Google Scholar]
  10. Cohen J. C., Noakes T. D., Benade A. J. Postprandial lipemia and chylomicron clearance in athletes and in sedentary men. Am J Clin Nutr. 1989 Mar;49(3):443–447. doi: 10.1093/ajcn/49.3.443. [DOI] [PubMed] [Google Scholar]
  11. Cohn J. S., Johnson E. J., Millar J. S., Cohn S. D., Milne R. W., Marcel Y. L., Russell R. M., Schaefer E. J. Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters. J Lipid Res. 1993 Dec;34(12):2033–2040. [PubMed] [Google Scholar]
  12. Cohn J. S., McNamara J. R., Cohn S. D., Ordovas J. M., Schaefer E. J. Plasma apolipoprotein changes in the triglyceride-rich lipoprotein fraction of human subjects fed a fat-rich meal. J Lipid Res. 1988 Jul;29(7):925–936. [PubMed] [Google Scholar]
  13. Cohn J. S., McNamara J. R., Cohn S. D., Ordovas J. M., Schaefer E. J. Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res. 1988 Apr;29(4):469–479. [PubMed] [Google Scholar]
  14. Dallongeville J., Lussier-Cacan S., Davignon J. Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J Lipid Res. 1992 Apr;33(4):447–454. [PubMed] [Google Scholar]
  15. Davignon J., Gregg R. E., Sing C. F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988 Jan-Feb;8(1):1–21. doi: 10.1161/01.atv.8.1.1. [DOI] [PubMed] [Google Scholar]
  16. Dergunov A. D., Rosseneu M. The significance of apolipoprotein E structure to the metabolism of plasma triglyceride-rich lipoproteins. Biol Chem Hoppe Seyler. 1994 Aug;375(8):485–495. doi: 10.1515/bchm3.1994.375.8.485. [DOI] [PubMed] [Google Scholar]
  17. Eto M., Watanabe K., Iwashima Y., Morikawa A., Oshima E., Sekiguchi M., Ishii K. Apolipoprotein E polymorphism and hyperlipemia in type II diabetics. Diabetes. 1986 Dec;35(12):1374–1382. doi: 10.2337/diab.35.12.1374. [DOI] [PubMed] [Google Scholar]
  18. Fielding P. E., Ishikawa Y., Fielding C. J. Apolipoprotein E mediates binding of normal very low density lipoprotein to heparin but is not required for high affinity receptor binding. J Biol Chem. 1989 Jul 25;264(21):12462–12466. [PubMed] [Google Scholar]
  19. Gianturco S. H., Brown F. B., Gotto A. M., Jr, Bradley W. A. Receptor-mediated uptake of hypertriglyceridemic very low density lipoproteins by normal human fibroblasts. J Lipid Res. 1982 Sep;23(7):984–993. [PubMed] [Google Scholar]
  20. Gregg R. E., Zech L. A., Schaefer E. J., Stark D., Wilson D., Brewer H. B., Jr Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest. 1986 Sep;78(3):815–821. doi: 10.1172/JCI112645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Gueguen R., Visvikis S., Steinmetz J., Siest G., Boerwinkle E. An analysis of genotype effects and their interactions by using the apolipoprotein E polymorphism and longitudinal data. Am J Hum Genet. 1989 Nov;45(5):793–802. [PMC free article] [PubMed] [Google Scholar]
  22. HAVEL R. J., EDER H. A., BRAGDON J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955 Sep;34(9):1345–1353. doi: 10.1172/JCI103182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hallman D. M., Boerwinkle E., Saha N., Sandholzer C., Menzel H. J., Csázár A., Utermann G. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet. 1991 Aug;49(2):338–349. [PMC free article] [PubMed] [Google Scholar]
  24. Havel R. J., Kotite L., Vigne J. L., Kane J. P., Tun P., Phillips N., Chen G. C. Radioimmunoassay of human arginine-rich apolipoprotein, apoprotein E. Concentration in blood plasma and lipoproteins as affected by apoprotein E-3 deficiency. J Clin Invest. 1980 Dec;66(6):1351–1362. doi: 10.1172/JCI109988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Havel R. J. Postprandial hyperlipidemia and remnant lipoproteins. Curr Opin Lipidol. 1994 Apr;5(2):102–109. doi: 10.1097/00041433-199404000-00006. [DOI] [PubMed] [Google Scholar]
  26. Havel R. McCollum Award Lecture, 1993: triglyceride-rich lipoproteins and atherosclerosis--new perspectives. Am J Clin Nutr. 1994 Apr;59(4):795–796. doi: 10.1093/ajcn/59.4.795. [DOI] [PubMed] [Google Scholar]
  27. Imari Y., Koga S., Ibayashi H. Phenotypes of apolipoprotein E and abnormalities in lipid metabolism in patients with non-insulin-dependent diabetes mellitus. Metabolism. 1988 Dec;37(12):1134–1138. doi: 10.1016/0026-0495(88)90189-8. [DOI] [PubMed] [Google Scholar]
  28. Kashyap M. L., Barnhart R. L., Srivastava L. S., Perisutti G., Allen C., Hogg E., Glueck C. J., Jackson R. L. Alimentary lipemia: plasma high-density lipoproteins and apolipoproteins CII and CIII in healthy subjects. Am J Clin Nutr. 1983 Feb;37(2):233–243. doi: 10.1093/ajcn/37.2.233. [DOI] [PubMed] [Google Scholar]
  29. Kobori S., Nakamura N., Uzawa H., Shichiri M. Influence of apolipoprotein E polymorphism on plasma lipid and apolipoprotein levels, and clinical characteristics of type III hyperlipoproteinemia due to apolipoprotein E phenotype E2/2 in Japan. Atherosclerosis. 1988 Jan;69(1):81–88. doi: 10.1016/0021-9150(88)90291-2. [DOI] [PubMed] [Google Scholar]
  30. Kotite L., Bergeron N., Havel R. J. Quantification of apolipoproteins B-100, B-48, and E in human triglyceride-rich lipoproteins. J Lipid Res. 1995 Apr;36(4):890–900. [PubMed] [Google Scholar]
  31. Krasinski S. D., Cohn J. S., Russell R. M., Schaefer E. J. Postprandial plasma vitamin A metabolism in humans: a reassessment of the use of plasma retinyl esters as markers for intestinally derived chylomicrons and their remnants. Metabolism. 1990 Apr;39(4):357–365. doi: 10.1016/0026-0495(90)90249-c. [DOI] [PubMed] [Google Scholar]
  32. Krieger M., Herz J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem. 1994;63:601–637. doi: 10.1146/annurev.bi.63.070194.003125. [DOI] [PubMed] [Google Scholar]
  33. Lopez-Miranda J., Ordovas J. M., Mata P., Lichtenstein A. H., Clevidence B., Judd J. T., Schaefer E. J. Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol. J Lipid Res. 1994 Nov;35(11):1965–1975. [PubMed] [Google Scholar]
  34. Mattson F. H., Grundy S. M. Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J Lipid Res. 1985 Feb;26(2):194–202. [PubMed] [Google Scholar]
  35. Pagnan A., Havel R. J., Kane J. P., Kotite L. Characterization of human very low density lipoproteins containing two electrophoretic populations: double pre-beta lipoproteinemia and primary dysbetalipoproteinemia. J Lipid Res. 1977 Sep;18(5):613–622. [PubMed] [Google Scholar]
  36. Pagnan A., Zanetti G., Bonanome A., Biffanti S., Ehnholm C., Keso L., Lukka M. Apolipoprotein E polymorphism, serum lipids and occurrence of "double pre-betalipoproteinemia' (DPBL) in subjects from two different populations. Atherosclerosis. 1987 May;65(1-2):23–28. doi: 10.1016/0021-9150(87)90004-9. [DOI] [PubMed] [Google Scholar]
  37. Schneeman B. O., Kotite L., Todd K. M., Havel R. J. Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):2069–2073. doi: 10.1073/pnas.90.5.2069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Steinmetz A., Jakobs C., Motzny S., Kaffarnik H. Differential distribution of apolipoprotein E isoforms in human plasma lipoproteins. Arteriosclerosis. 1989 May-Jun;9(3):405–411. doi: 10.1161/01.atv.9.3.405. [DOI] [PubMed] [Google Scholar]
  39. Stengård J. H., Zerba K. E., Pekkanen J., Ehnholm C., Nissinen A., Sing C. F. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation. 1995 Jan 15;91(2):265–269. doi: 10.1161/01.cir.91.2.265. [DOI] [PubMed] [Google Scholar]
  40. Superko H. R., Haskell W. L. The effect of apolipoprotein E isoform difference on postprandial lipoprotein in patients matched for triglycerides, LDL-cholesterol, and HDL-cholesterol. Artery. 1991;18(6):315–325. [PubMed] [Google Scholar]
  41. Tiret L., de Knijff P., Menzel H. J., Ehnholm C., Nicaud V., Havekes L. M. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS Study. European Atherosclerosis Research Study. Arterioscler Thromb. 1994 Oct;14(10):1617–1624. doi: 10.1161/01.atv.14.10.1617. [DOI] [PubMed] [Google Scholar]
  42. Utermann G. Apolipoprotein E polymorphism in health and disease. Am Heart J. 1987 Feb;113(2 Pt 2):433–440. doi: 10.1016/0002-8703(87)90610-7. [DOI] [PubMed] [Google Scholar]
  43. Utermann G., Pruin N., Steinmetz A. Polymorphism of apolipoprotein E. III. Effect of a single polymorphic gene locus on plasma lipid levels in man. Clin Genet. 1979 Jan;15(1):63–72. [PubMed] [Google Scholar]
  44. Warnick G. R., Benderson J., Albers J. J. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 1982 Jun;28(6):1379–1388. [PubMed] [Google Scholar]
  45. Weintraub M. S., Eisenberg S., Breslow J. L. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest. 1987 Dec;80(6):1571–1577. doi: 10.1172/JCI113243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Weintraub M. S., Eisenberg S., Breslow J. L. Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil. J Clin Invest. 1987 Apr;79(4):1110–1119. doi: 10.1172/JCI112926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Weisgraber K. H. Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112. J Lipid Res. 1990 Aug;31(8):1503–1511. [PubMed] [Google Scholar]
  48. Weisgraber K. H. Apolipoprotein E: structure-function relationships. Adv Protein Chem. 1994;45:249–302. doi: 10.1016/s0065-3233(08)60642-7. [DOI] [PubMed] [Google Scholar]
  49. Weisgraber K. H., Innerarity T. L., Mahley R. W. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J Biol Chem. 1982 Mar 10;257(5):2518–2521. [PubMed] [Google Scholar]
  50. Weisgraber K. H., Mahley R. W. Apoprotein (E--A-II) complex of human plasma lipoproteins. I. Characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction. J Biol Chem. 1978 Sep 10;253(17):6281–6288. [PubMed] [Google Scholar]
  51. Wilson P. W., Myers R. H., Larson M. G., Ordovas J. M., Wolf P. A., Schaefer E. J. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA. 1994 Dec 7;272(21):1666–1671. [PubMed] [Google Scholar]
  52. van't Hooft F., Havel R. J. Metabolism of chromatographically separated rat serum lipoproteins specifically labeled with 125I-apolipoprotein E. J Biol Chem. 1981 Apr 25;256(8):3963–3968. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES